Element concentrations in serum, erythrocytes, hair and urine of alopecia patients.
Study Design
- نوع الدراسة
- Cross-Sectional Study
- التدخل
- Element concentrations in serum, erythrocytes, hair and urine of alopecia patients. None
- المقارن
- Placebo
- اتجاه التأثير
- Neutral
- خطر التحيز
- Moderate
Abstract
The trace element concentrations of Se, Rb, Zn, Fe, Co, Cs, Mg, Ca, F, Cu, Cr and Ag in serum and of Se, Rb, Zn, Fe, Co and Cs in red cells of Finnish alopecia patients were determined. In addition the Cu and Zn content in 24 h urine and Cu, Zn, Cd, Cr and Se concentrations in the hair of these patients were studied. No differences in element concentrations of the samples mentioned above as compared to those of the normal population could be found. In addition, there was no tendency of excesses or deficiences of elements analysed in the samples. Statistically significant difference was found between the copper content of serum in alopecia areata and alopecia universalis patients and also between the copper content of serum in alopecia areata plus alopecia totalis and alopecia universalis patients. The selenium concentration in serum samples of a few patients was low, but this is in agreement with the fact that the selenium content in the Finnish population is low due to the scanty content of selenium in food.
باختصار
The selenium concentration in serum samples of a few patients was low, but this is in agreement with the fact that the seenium content in the Finnish population is low due to the scanty content of selenarium in food.
Used In Evidence Reviews
Similar Papers
Nature · 2010
Genome-wide association study in alopecia areata implicates both innate and adaptive immunity.
Journal of the American Academy of Dermatology · 2006
The diagnosis and treatment of iron deficiency and its potential relationship to hair loss.
Inflammatory bowel diseases · 2012
Micronutrient deficiencies in inflammatory bowel disease: from A to zinc.
Cannabis and cannabinoid research · 2021
A Review of Hemp as Food and Nutritional Supplement.
The Journal of pharmacology and experimental therapeutics · 2021
The Pharmacological Case for Cannabigerol.
Medical cannabis and cannabinoids · 2018